Progenics Pharmaceuticals, Inc. is now a
subsidiary of Lantheus Holdings, Inc.
646-975-2500
Contact Us
Pipeline
Approved Products
AZEDRA – Ultra-Orphan Radiotherapeutic
In Development
PyL – PSMA Targeted PET Imaging Agent
1095 – Small Molecule Therapeutic
Clinical Trials
Overview
Investors
Overview
Proxy Materials
2019 Annual Shareholder Meeting Proxy Materials
Financial Information/Reports
SEC Filings
Quarterly Results
Press Releases
Business Development
Overview
Become A Partner
About Us
Vision
Management Team
Board of Directors
Compliance Program
Careers
Contact Us
Registration has been disabled.
